Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,814 | 77 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $522.44 | 8 | $0 (2022) |
| Optinose US, Inc. | $311.25 | 19 | $0 (2023) |
| GENZYME CORPORATION | $173.92 | 7 | $0 (2024) |
| Acclarent, Inc | $143.91 | 5 | $0 (2020) |
| GlaxoSmithKline, LLC. | $142.97 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $139.17 | 6 | $0 (2024) |
| Intersect ENT, Inc. | $68.84 | 4 | $0 (2021) |
| AERIN MEDICAL INC. | $60.52 | 3 | $0 (2024) |
| Entellus Medical, Inc. | $39.53 | 3 | $0 (2017) |
| Lannett Company Inc | $34.78 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $216.79 | 9 | GENZYME CORPORATION ($122.98) |
| 2023 | $269.62 | 16 | Optinose US, Inc. ($156.13) |
| 2022 | $286.45 | 11 | OptiNose US, Inc. ($98.01) |
| 2021 | $98.45 | 5 | Stryker Corporation ($24.67) |
| 2020 | $171.39 | 3 | Stryker Corporation ($139.18) |
| 2019 | $411.29 | 13 | Stryker Corporation ($244.47) |
| 2018 | $209.09 | 10 | Acclarent, Inc ($125.85) |
| 2017 | $151.17 | 10 | Entellus Medical, Inc. ($39.53) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Immunology | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Immunology | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Immunology | ||||||
| 04/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Immunology | ||||||
| 02/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/30/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: EAR NOSE & THROAT | ||||||
| 01/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Immunology | ||||||
| 12/05/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/26/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/11/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/02/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/24/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/22/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Immunology | ||||||
| 08/11/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/17/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/22/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/25/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/22/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/13/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 01/31/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 01/17/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 114 | 128 | $32,210 | $7,786 |
| 2022 | 5 | 105 | 123 | $31,007 | $7,626 |
| 2021 | 5 | 137 | 164 | $41,532 | $10,269 |
| 2020 | 5 | 136 | 158 | $32,083 | $6,927 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 42 | $9,156 | $2,587 | 28.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $10,016 | $2,346 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,680 | $1,651 | 21.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 34 | 38 | $5,358 | $1,202 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 51 | $11,118 | $2,865 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $5,321 | $1,392 | 26.2% |
| 70486 | Ct scan of face without contrast | Office | 2022 | 11 | 12 | $4,776 | $1,194 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $5,280 | $1,175 | 22.3% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 29 | 32 | $4,512 | $999.19 | 22.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 67 | $14,606 | $4,174 | 28.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 33 | 33 | $10,329 | $2,210 | 21.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $6,720 | $1,711 | 25.5% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 34 | 39 | $5,499 | $1,235 | 22.5% |
| 70486 | Ct scan of face | Office | 2021 | 11 | 11 | $4,378 | $938.44 | 21.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 26 | 26 | $8,142 | $1,761 | 21.6% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 40 | 46 | $6,492 | $1,340 | 20.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $5,285 | $1,293 | 24.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 27 | $5,882 | $1,289 | 21.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 36 | 48 | $6,282 | $1,245 | 19.8% |
About Dr. John Bennett, MD
Dr. John Bennett, MD is a Otolaryngology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1699800227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Bennett, MD has received a total of $1,814 in payments from pharmaceutical and medical device companies, with $216.79 received in 2024. These payments were reported across 77 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,814).
As a Medicare-enrolled provider, Bennett has provided services to 492 Medicare beneficiaries, totaling 573 services with total Medicare billing of $32,608. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Salt Lake City, UT
- Active Since 02/22/2007
- Last Updated 07/08/2007
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1699800227
Products in Payments
- DUPIXENT (Biological) $313.09
- Xhance (Drug) $311.25
- SPIROX - LATERA (Device) $244.47
- NAV - NEW PRODUCT DEVELOPMENT (Device) $139.18
- NUCALA (Biological) $129.64
- SCOPIS ENT (Device) $122.49
- ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM (Device) $72.54
- XprESS Multi-Sinus Dilation System (Device) $39.53
- C Topical Solution 4 CII (Drug) $34.78
- Acclarent ENT Navigation System (Device) $33.94
- PROPEL (Device) $27.87
- Doc Band (Device) $25.64
- Vivaer RF Stylus (Device) $24.32
- SINUVA (Drug) $21.38
- ACCLARENT Balloon Inflation Device (Device) $19.37
- RELIEVA SpinPlus NAV Balloon Sinusplasty System (Device) $18.06
- Oralair (Drug) $17.68
- VIVAER STYLUS (Device) $16.38
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $16.30
- Amitiza (Drug) $15.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Salt Lake City
Dr. Preston Ward, Md, MD
Otolaryngology — Payments: $136,457
Mr. Steven Miller, M.d, M.D
Otolaryngology — Payments: $33,308
Paul Krakovitz, Md, MD
Otolaryngology — Payments: $17,645
Matthew Dahl, Md, MD
Otolaryngology — Payments: $13,445
Joshua Bradley, M.d, M.D
Otolaryngology — Payments: $2,210
Mana Espahbodi, Md, MD
Otolaryngology — Payments: $2,043